Abstract:The Genus Diospyros has garnered significant scientific interest due to its diverse bioactivities, attributed to various phytochemicals like flavonoids, terpenoids, and xanthones. Several species, including D. lotus, D. kaki, and D. tricolor, exhibit promising anti‐cancer properties through in vitro and in vivo studies, demonstrating inhibition of proliferation, induction of apoptosis, and mitigation of angiogenesis. Integrating traditional knowledge with modern research, Diospyros shows potential as a source for novel and effective anti‐cancer therapeutics in ethno‐pharmacology. The genus Diospyros has gained significant attention in the scientific community owing to its diverse bioactivities ascribed to specific bioactive constituents present in different species of this plant. Phytochemicals like flavonoids, terpenoids, and xanthones have been reported to be present in other Diospyros species responsible for their pharmacological properties. These compounds are well known for their diverse potent therapeutic potentials, such as antimicrobial, antioxidant, anti‐inflammatory, and anticancer properties. This review enlightens the details of the Genus Diospyros, ranging from an overview of its species to an in‐depth analysis of phytochemistry, ethnopharmacology, and their potential as anticancer agents. Different species, including Diospyros lotus, Diospyros kaki, Diospyros maritima, Diospyros mespiliformis, and Diospyros tricolor, presented with an enormous range of anticancer activities against human cancer cell cultures. Moreover, this review highlights the results of various in vitro (antiproliferative, cytotoxic effects against), in vivo (inhibition of tumor, apoptosis), and in silico (GLU234, GLU278, and LYS158 protein residues) studies, elucidating its preclinical anticancer potential. The anticancer potential displays inhibition of cellular proliferation, induction of apoptosis, and mitigation of angiogenesis. Furthermore, this review may elaborate the use of traditional knowledge, modern research, and potential therapeutic applications in the field of anticancer ethnopharmacology. As the modern‐day research approaches novel alternatives to combat diseases like cancer, the Genus Diospyros may emerge as a promising avenue with the potential to yield innovative and effective therapeutic agents.

Diosmetin: A dietary flavone as modulator of signaling pathways in cancer progression

Unveiling the Molecular Mechanism of Diosmetin and its Impact on Multifaceted Cellular Signaling Pathways

Anticancer therapeutic potential of genus Diospyros: From phytochemistry to clinical applications—A review

Diosmetin as a promising natural therapeutic agent: In vivo, in vitro mechanisms, and clinical studies

Diosmetin and tamarixetin (methylated flavonoids): A review on their chemistry, sources, pharmacology, and anticancer properties

Flavonoid display ability to target microRNAs in cancer pathogenesis

Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review

Diosmetin, a Potential P53 Activator, Performs Anticancer Effect by Regulating Cell Cycling and Cell Proliferation in HepG2 Cells.

Anti-Proliferation and Pro-Apoptotic Effects of Diosmetin Via Modulating Cell Cycle Arrest and Mitochondria-Mediated Intrinsic Apoptotic Pathway in MDA-MB-231 Cells

Diosmetin induces apoptosis and protective autophagy in human gastric cancer HGC-27 cells via the PI3K/Akt/FoxO1 and MAPK/JNK pathways

Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer

Diosmetin Induces Modulation of Igf-1 and Il-6 Levels to Alter Rictor-Akt-PKCα Cascade in Inhibition of Prostate Cancer

Hesperidin, a Bioflavonoid in Cancer Therapy: A Review for a Mechanism of Action through the Modulation of Cell Signaling Pathways

Diet-derived Flavonoids: Bridging Epidemiological Chemoprevention and Preclinical Anti-tumor Mechanisms in Clinical Oncology

Dietary Phytochemicals in Cancer Signalling Pathways: Role of miRNA Targeting

Effects of Diosmetin on Nine Cytochrome P450 Isoforms, UGTs and Three Drug Transporters in Vitro

Can We Improve Diosmetin Activity? The State-of-the-Art and Promising Research Directions

Flavonoids Nanoparticles in Cancer: Treatment, Prevention and Clinical Prospects.

Diosmetin Induces Apoptosis and Enhances the Chemotherapeutic Efficacy of Paclitaxel in Non-Small Cell Lung Cancer Cells Via Nrf2 Inhibition.

Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects

Targeting epigenetics in cancer: therapeutic potential of flavonoids